Metoprolol 25 mg clinical studies
Pro Research Analysisby 
Searched over 200M research papers
Metoprolol 25 mg in Hypertension: Clinical Efficacy and Safety
Several clinical studies have evaluated the effectiveness and safety of metoprolol 25 mg, often as part of a fixed-dose combination, in the management of hypertension. In a multicenter, double-blind, randomized trial involving Indian hypertensive patients, a fixed-dose combination of Efonidipine 40 mg and S(-) Metoprolol 25 mg led to significant reductions in both systolic and diastolic blood pressure over 90 days. By the end of the study, 95% of patients achieved target blood pressure (<140/90 mmHg), and the treatment was well tolerated with only mild adverse events reported, similar to comparator groups . Another randomized controlled trial compared a fixed combination of metoprolol XL 25 mg and amlodipine 2.5 mg to monotherapies and found that all regimens, including metoprolol 25 mg alone, significantly reduced blood pressure over 8 weeks, with high responder and control rates and no serious adverse events . Real-world data from a large Indian cohort also demonstrated that a fixed-dose combination containing metoprolol 25 or 50 mg, telmisartan, and chlorthalidone effectively reduced blood pressure across all BMI categories and was well tolerated .
Metoprolol 25 mg in Heart Failure and Cardiomyopathy
Metoprolol has also been studied in patients with heart failure and dilated cardiomyopathy. In a randomized trial, patients with idiopathic dilated cardiomyopathy received metoprolol at doses starting from 25 mg, titrated up to 100 mg daily. The study found significant improvements in cardiac function, New York Heart Association (NYHA) class, and survival rates over two to three years compared to placebo . Another trial in patients with heart failure and coronary artery disease, using metoprolol titrated up to 100 mg daily, showed reduced hospital admissions, improved functional class, increased ejection fraction, and longer exercise duration, with no serious adverse reactions . In the large MERIT-HF trial, metoprolol CR/XL (starting at 25 mg once daily for NYHA II patients) significantly reduced all-cause mortality and sudden deaths in chronic heart failure patients, and was well tolerated .
Metoprolol 25 mg in Special Populations and Conditions
A randomized controlled trial investigated the use of metoprolol 25 mg in recently bereaved individuals and found that a 6-week course of low-dose metoprolol and aspirin reduced physiological and psychological markers of cardiovascular risk, such as blood pressure, heart rate, anxiety, and depression, without significant adverse effects . However, in patients with Eisenmenger syndrome, metoprolol succinate therapy (25 mg once or twice daily) did not improve exercise capacity or clinical outcomes over 16 weeks and was associated with a trend toward worsening heart failure .
Metabolic Effects of Metoprolol 25 mg
Long-term use of metoprolol, even at lower doses, has been associated with mild metabolic changes. In a crossover study comparing metoprolol and atenolol, both drugs caused small increases in fasting plasma insulin, blood glucose, and glycated hemoglobin, as well as changes in lipid profiles, suggesting a decrease in insulin sensitivity and potential metabolic side effects .
Conclusion
Clinical studies consistently show that metoprolol 25 mg, whether used alone or in combination with other antihypertensive agents, is effective and generally well tolerated for lowering blood pressure in patients with hypertension. It also provides significant benefits in heart failure and cardiomyopathy when added to standard therapy. However, its use in certain populations, such as those with Eisenmenger syndrome, may not confer the same benefits and could be associated with adverse outcomes. Mild metabolic effects may occur with long-term use. Overall, metoprolol 25 mg remains a valuable option in cardiovascular therapy, with its efficacy and safety profile supported by multiple clinical studies 1245+5 MORE.
Sources and full results
Most relevant research papers on this topic